DXM Abuse Prevention Act of 2017
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 1, 2017)
DXM Abuse Prevention Act of 2017
This bill amends the Federal Food, Drug, and Cosmetic Act to: (1) require a retailer that sells certain drugs containing dextromethorphan (DXM) to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer, (2) establish other restrictions on the sale of over-the-counter drugs containing DXM, and (3) establish restrictions on the distribution of bulk DXM.
What just happenedMar 17, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMar 1, 2017
- Mar 17, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 1, 2017IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 1, 2017IntroReferralIntro-H
Introduced in House
- Mar 1, 2017IntroReferral1000
Introduced in House